EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, M.
Right arrow Articles by Kim, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, M.
Right arrow Articles by Kim, S.
Experimental Biology and Medicine 228:749-758 (2003)
© 2003 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Activation of Selective Transcription Factors and Cytokines by Water-Soluble Extract from Lentinus lepideus

Mirim Jin*, Hyung Jin Jung*, Jeong June Choi{ddagger}, Hyang Jeon*, Jin Hwan Oh*, Bongcheol Kim*, Sung Seup Shin*, Jong Kyu Lee{dagger}, Keejung Yoon{ddagger} and Sunyoung Kim*,{ddagger},1

* PanGenomics Co. Ltd., Biotechnology Incubating Center, Seoul 151-742, Korea;
{dagger} Tree Pathology and Mycology Laboratory, Kangwon National University, Chunchon, 200-701, Korea;
{ddagger} School of Biological Science and Institute of Molecular Biology and Genetics, Seoul National University, Seoul 151-742, Korea

We isolated a water-soluble extract, PG101, from cultured mycelia of Lentinus lepideus. Treatment of human peripheral blood mononuclear cells (PBMCs) with PG101 increased levels of TNF-{alpha}, IL-1ß, IL-10, and IL-12 by 100- to 1000-fold, whereas GM-CSF and IL-18 were activated by an order of magnitude. On the contrary, IFN-{gamma} and IL-4 were not affected. The response to PG101 occurred in a dose- and time-dependent manner. From the human PBMCs treated with PG101, TNF-{alpha} was a first cytokine to be activated, detectable at 2 hr post-treatment followed by IL-1ß at 6 hr post-treatment. IL-12 and IL-10 were the next to follow. GM-CSF and IL-18 both showed significant increases 24 hr after treatment. When PBMCs were sorted into various cell types, monocyte/macrophages, but not T and B cells, were the major target cell type responsive to PG101. Consistent with this result, the profile of cytokine expression upon PG101 treatment was comparable between PBMCs and a human promonocytic cell line (U937), whereas cell lines of T cell and myeloid origins did not respond to PG101. Data from a transient transfection assay involving specific reporter plasmids indicated that cellular transcription factor such as NF-{kappa}B, but not AP-1, was highly activated by PG101. Results from a gel retardation assay and the experiment involving a specific NF-{kappa}B inhibitor confirmed the involvement of NF-{kappa}B. Despite its significant biological effect on various cytokines, PG101 remained nontoxic in both rats and PBMCs even at a biological concentration approximately 20 times greater. PG101 demonstrates great potential as a therapeutic immune modulator.

Key Words: Lentinus lepideus • PG101 • immune modulator • monocyte/macrophage • cytokines • transcription factor • NF-{kappa}B




This article has been cited by other articles:


Home page
Infect. Immun.Home page
P. Zhang, M. Martin, S. M. Michalek, and J. Katz
Role of Mitogen-Activated Protein Kinases and NF-{kappa}B in the Regulation of Proinflammatory and Anti-Inflammatory Cytokines by Porphyromonas gingivalis Hemagglutinin B
Infect. Immun., July 1, 2005; 73(7): 3990 - 3998.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Jin, H. Jeon, H. J. Jung, B. Kim, S. S. Shin, J. J. Choi, J. K. Lee, C.-Y. Kang, and S. Kim
Enhancement of Repopulation and Hematopoiesis of Bone Marrow Cells in Irradiated Mice by Oral Administration of PG101, a Water-Soluble Extract from Lentinus lepideus
Experimental Biology and Medicine, June 1, 2003; 228(6): 759 - 766.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Experimental Biology and Medicine.